Elsevier

Brain Research

Volume 1530, 12 September 2013, Pages 13-21
Brain Research

Research Report
The cell adhesion molecule L1 regulates the expression of FGF21 and enhances neurite outgrowth

https://doi.org/10.1016/j.brainres.2013.07.043Get rights and content

Highlights

  • L1 promotes the expression and secretion of FGF21.

  • Activation of L1 promotes neurite outgrowth, expression and secretion of FGF21 in L1wt mice, but not L1ko mice.

  • FGF21 promotes the neurite outgrowth of neurons isolated from L1wt mice and L1ko mice.

  • Both FGF21 shRNA and inhibitor of FGF receptor block the neurite outgrowth induced by L1 antibody.

  • FGF21/FGFR signaling is involved in the L1 enhanced neurite outgrowth.

Abstract

L1 plays a role in neural development. However, it remains unclear how L1 plays this role. In the present study, we have shown extensive outgrowth of long neurites in cerebellar neurons after treatment with either L1 or L1 antibody. Notably, the mRNA level of FGF21 was significantly increased in both L1 and L1 antibody treated neurons compared to control group. Consistently, the neurite outgrowth promoted by L1 was strongly inhibited by siRNA against FGF21 gene or a treatment of cells with FGFR inhibitor. These results demonstrate that FGF21/FGFR signaling promotes the neurite outgrowth in a L1-dependent manner.

Introduction

Neurites outgrowth is the fundamental basis of neural communication. Many neurodegenerative diseases are defined by the destruction of neurites (Noorbakhsh et al., 2009). It is known that appropriate neurite outgrowth and neuronal differentiation in a timely and ordered manner are decisive in developing therapies to promote axon regeneration after nerve injury in neurodegenerative diseases. Thus, there is a need for identifying molecules that affect the differentiation of neurons and neurite outgrowth to represent a promising strategy for neural regeneration. The neural cell adhesion molecule L1 is a member of the immunoglobulin superfamily predominantly expressed by postmitotic neurons in the central nervous system (CNS) (Wright et al., 2007, Rathjen and Schachner, 1984). During CNS development, L1 is targeted to the surface of developing axons and growth cones, and mediates outgrowth, adhesion, fasciculation and guidance of axons as well as neuronal migration and survival (Noorbakhsh et al., 2009, Wright et al., 2007, Rathjen and Schachner, 1984, Hortsch, 2003). Various human genetic disorders with prominent nervous system defects are caused by mutations in L1 at human chromosomal locus Xq28 (Kenwrick et al., 2000). Recently, using a murine embryonic stem cell line that constitutively expressed L1 at all stages of neural differentiation, we have shown L1 promotes neurogenesis in vitro (data not published). However, it remains unknown how L1 regulates neurite outgrowth.

Fibroblast growth factor (FGF) 21 is a FGF family member produced by liver and other tissues such as white adipose tissue (WAT), skeletal muscle, and pancreatic β cells (Kharitonenkov et al., 2005, Itoh, 2010). Although FGF21 possesses a canonical ‘FGF-like’ domain and shares significant sequence homology with the other FGFs (Kharitonenkov et al., 2005, Itoh, 2010), it is unable to act on fibroblasts, and FGF21 does not promote growth in vivo. Indeed, FGF21 transgenic mice or delivery of pharmacological doses of FGF21 to rodents and primates had no effect on tissue growth (Kharitonenkov et al., 2005, Itoh, 2010, Badman et al., 2009, Wu et al., 2010). Hence, FGF21 is considered to be a metabolic hormone rather than a traditional growth factor (Kharitonenkov et al., 2005, Itoh, 2010, Wu et al., 2010). Various studies on FGF21 suggested that FGF21 regulates energy balance and improves glucose homeostasis (Kharitonenkov et al., 2005, Adams et al., 2012). The important metabolic effects of FGF21 include increase of glucose uptake in adipocytes, reduction of glucose and triglyceride levels in obese mice (Kharitonenkov and Shanafelt, 2008), increase of energetic waste and induction of weight loss (Kharitonenkov et al., 2005, Badman et al., 2009), promotion of fatty acid oxidation and increment on ketone bodies formation (Badman et al., 2009, Kharitonenkov and Shanafelt, 2008, Coskun et al., 2008, Badman et al., 2007). Sarruf et al. showed the central FGF21 action in the brain for the first time (Sarruf et al., 2010). Accumulated evidence indicates that the CNS changes levels of key hormones and nutrients in adaptive adjustment to insulin sensitivity in the circulation (Schwartz and Porte, 2005). In this study, we have investigated the role of FGF21 in L1 regulated neurite outgrowth by comparatively analyzing the differential expression of FGF21 between L1 wild type (wt) mice and knockout (ko) mice, which may be important to neurite outgrowth. We demonstrate that L1 can promote the expression and secretion of FGF21, thereby enhancing neurite outgrowth through the activation of FGF21/FGFR signaling.

Section snippets

Activated L1 promotes neurite outgrowth

L1 is predominantly expressed by postmitotic neurons of the CNS (Rathjen and Schachner, 1984, Maness and Schachner, 2006). By activating diverse signal transduction, L1 plays key roles during development and regeneration (Kiryushko et al., 2004). To further support this notion, we measured the neurite length to analyze the change of cell morphology with different concentrations of L1 (Supplementary Fig. 1A). Fc treatment was used as a control. The length of the longest neurite (Supplementary

Discussion

In the present study, we have shown that levels of both FGF21 mRNA and protein are significantly increased in neurons treated by either L1 or L1 antibody. The neurite outgrowth promoted by L1 is strongly inhibited by siRNA against FGF21 gene or the treatment with FGFR inhibitor. These results demonstrate that FGF21/FGFR signaling is involved in the L1 enhanced neurite outgrowth.

Several studies have documented that during CNS development, L1 is involved in developing axons and growth cones and

Antibodies and reagents

Anti-β-actin mouse IgG, anti-FGF21 rabbit IgG, goat anti-rabbit IgG-horseradish peroxidase and goat anti-mouse IgG-horseradish peroxidase were purchased from Santa Cruz Biotechnology. Anti-β-tubulin III antibody was purchased from Covance Inc. The monoclonal anti-mouse L1 antibody 557 and L1 molecule was produced and purified as previously described (Appel et al., 1995). FITC-conjugated rat anti-mouse IgM monoclonal antibodies were purchased from BD Biosciences. FGFR Inhibitor SU5402 was

Authors Contributions

XHH and JLH performed majority of the experiments. XHH and ZCX wrote the manuscript. YL performed some experiments. ZZYY, HMZ, KLM and LZ provided technical support and help. MS, ZCX and YLL participated actively in discussion of the project and editorial work of the manuscript.

Acknowledgments

This work was supported by grants to Y.L. Li from National Natural Science Foundation of China (31070728) and Liaoning Province education bureau (L2010103); and to Z.C. Xiao from Talent Program of Yunnan Province, China, and The Professorial Fellowship of Monash University.

References (35)

  • M.K. Badman et al.

    Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis

    Endocrinology

    (2009)
  • J. Chen et al.

    Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury

    Brain

    (2007)
  • T. Coskun et al.

    Fibroblast growth factor 21 corrects obesity in mice

    Endocrinology

    (2008)
  • T.K. Fon et al.

    Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse

    Mol. Endocrinol.

    (2010)
  • R. Goetz et al.

    Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

    Mol. Cell. Biol.

    (2007)
  • P. Grant et al.

    Neurofilament protein synthesis and phosphorylation

    J. Neurocytol.

    (2000)
  • M. Hortsch

    Drosophila Echinoid is an antagonist of Egfr signalling, but is not a member of the L1-type family of cell adhesion molecules

    Development

    (2003)
  • Cited by (20)

    • Growth factors and female reproduction in vertebrates

      2024, Molecular and Cellular Endocrinology
    • The L1 cell adhesion molecule affects protein kinase D1 activity in the cerebral cortex in a mouse model of Alzheimer's disease

      2020, Brain Research Bulletin
      Citation Excerpt :

      To investigate if PKD1 is a mediator for L1′s contribution to neuronal survival in response to oxidative stress and Aβ1−42 neurotoxicity, stressed neurons were treated with L1 with or without a PKD1 inhibitor. We found that inhibition of PKD1 activity fails to affect L1-mediated neuroprotection, implicating that other L1 signaling pathways, possibly mediated by myelin basic protein, casein kinase 2α, FGF21, and MAP2, may compensate for the inactivation of PKD1 (Lutz et al., 2014; Wang and Schachner, 2015; Huang et al., 2013; Poplawski et al., 2012). In summary, we propose that L1 may serve as a novel agent to increase PKD1 phosphorylation for neuroprotection in stressed cortical neurons under the pathological conditions of AD via a well-characterized PKC-independent activation mechanism (Hurd and Rozengurt, 2003; Jacamo et al., 2008) and in the following sequence: homophilic activation of L1 at the cell surface, activation of PKC and activation of PKD1 via PKC (Rozengurt et al., 2005).

    • Sensory axons inhibit motor axon regeneration in vitro

      2020, Experimental Neurology
      Citation Excerpt :

      L1CAM was initially shown to facilitate homophilic trans-binding of one axon to another (Lemmon et al., 1989). More recently, it has been found to stimulate regeneration through activation of the MAP kinase pathway in conjunction with the fibroblast growth factor receptor (FGFR; Huang et al., 2013; Schmid et al., 2000). To explore L1CAM function the preparation of Dual cultures was modified by electroporating DRG neurons with siRNA to L1CAM at the time of initial DRG harvest (Fig. 4).

    • Rare inherited missense variants of POGZ associate with autism risk and disrupt neuronal development

      2019, Journal of Genetics and Genomics
      Citation Excerpt :

      The L1CAM gene is expressed primarily in the nervous system, playing a crucial role in neuronal cell migration, axon guidance, neurite outgrowth and cell-cell interactions (Dahme et al., 1997; Kamiguchi, 2003; Kiefel et al., 2011; Menzel et al., 2016; Patzke et al., 2016). L1CAM has been reported to promote neurite outgrowth in cultured neurons (Williams et al., 1992, 1994; Hoffman et al., 2008; Huang et al., 2013; Colombo et al., 2014; Peng et al., 2016; Keenan et al., 2017), and the suppression of L1CAM in human neurons inhibits neurite extension (Patzke et al., 2016). However, we found that compared to control neurons, L1cam-suppressed cortical neurons exhibited a significant increase in the length of axons and total neurites.

    • The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential

      2018, Gene
      Citation Excerpt :

      KIF4 transports cell adhesion molecule L1, ribosomal protein P0 and integrins to axons (Sekine et al., 1994; Takemura et al., 1996; Bisbal et al., 2009; Heintz et al., 2014). L1 promote neurite outgrowth (Huang et al., 2013). KIF4 co-locates with integrins β1 and L1 in vesicles of neuronal and non-neuronal cells.

    • Using the shared genetics of dystonia and ataxia to unravel their pathogenesis

      2017, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Of the genes involved in neurogenesis, Copine1, which is encoded by CPNE9, regulates neurite outgrowth and differentiation of hippocampal progenitor cells (Park et al., 2012). In contrast, LCAM1 and NCDN, which encode cell adhesion molecule L1 and neurochondrin, respectively, modify neurite growth either in cerebellar neurons(Huang et al., 2013) or PC12 cells (Wang et al., 2013). The paired-like homeobox domain protein Phox2b is a key determinant of neuronal identity, as it is required for the initial phase in neuronal differentiation, giving rise to noradrenergic neurons that may be involved in the pathology of dystonia (Adams and Foote, 1988; Brunet and Pattyn, 2002).

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text